AnaptysBio
ANAB
ANAB
124 hedge funds and large institutions have $633M invested in AnaptysBio in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less funds holding
Funds holding: 131 → 124 (-7)
14% less capital invested
Capital invested by funds: $733M → $633M (-$100M)
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
Holders
124
Holding in Top 10
2
Calls
$5.03M
Puts
$205K
Top Buyers
| 1 | +$15.7M | |
| 2 | +$14.2M | |
| 3 | +$14M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$13.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.01M |
Top Sellers
| 1 | -$9.46M | |
| 2 | -$7.42M | |
| 3 | -$5.01M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.78M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$3.26M |